CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-14). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2496 · Search date 2026-08-14 · Methodology v0.7

Modern silver-containing dressings,
does it really help with Faster wound closure of partial-thickness burns than daily 1% silver sulfadiazine?

30-Second Summary
C
Evidence Grade C · 54 · Safety caution
Modern silver dressings showed faster healing than daily silver sulfadiazine, but the evidence is small and heterogeneous.
Silver dressings and silver sulfadiazine should be selected by clinicians according to burn depth, infection risk, allergy, and dressing schedule. This evidence does not support self-treatment of extensive or potentially infected burns.
What the
research shows
The grade is C. In a 70-participant randomized trial, closure took 10.0±3.0 days with Aquacel Ag versus 13.7±4.3 days with daily 1% silver sulfadiazine, a difference of -3.7 days (95% CI -5.44 to -1.96). A separate trial randomized 163 but lost 57 (35.0%) and analyzed 106; at least 50% healing by four weeks occurred in 25/31 versus 13/27 in its deep partial-thickness subgroup. Different dressings and outcomes and unverified blinded assessment give C with 54 points.
What the
ads claim
Modern dressings also contain silver. These trials did not compare silver with no treatment; they compared a less frequently changed silver dressing with daily silver-sulfadiazine cream.
*

Useful facts when choosing a product

  • Aquacel Ag was changed every three days, whereas silver-sulfadiazine cream was changed daily.
  • The Muangman confidence interval was calculated from public means, standard deviations, and 35 participants per arm; it was not directly reported by the paper.
  • Existing verdicts 057, 229, 950, 973, 1075, and 1114 cover adjacent burn, silver, or wound-care topics but not this exact comparator and closure claim; the pivotal PMID and DOI were not duplicated.
Gap Measurement · Verdict 2496 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Muangman randomized 70 outpatients with partial-thickness burns involving less than 15% body surface area, 35 per arm. The public full text states computer randomization but did not verify allocation concealment, participant or closure-assessor masking, or a prospectively registered primary endpoint. Adhya was an open-label parallel randomized trial: 163 were randomized, 57 (35.0%) dropped out, and evaluable data remained for 52 nanocrystalline-silver and 54 silver-sulfadiazine patients. Blinded wound assessment was not verified. The first trial had Siriraj institutional support; Adhya reported ‘Source of Support: DST West Bengal’.

02

Why this is classified as C (54)

A randomized trial showed a large difference in actual closure and a second trial pointed in the same direction, but the products and endpoints were not comparable enough for independent replication. Both bodies of evidence were small and blinded assessment was not verified. The hard outcome and large-effect strengths give C with 54 points.

Counterpoint. Fewer changes and reduced pain or cost may be separate advantages; this grade addresses only speed of partial-thickness burn closure.

Rejudgment record. Cross-check applied — We cross-checked randomized and evaluable counts, closure-time and healing-event results, assessor masking, and disclosed funding against the two primary reports.

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Aquacel Ag speeds partial-thickness burn closure versus daily silver sulfadiazine.CThe 70-participant trial found a 3.7-day mean difference without independent replication of the same estimate.
Nanocrystalline silver improves four-week healing of deep partial-thickness burns.CAt least 50% healing increased in a small subgroup, while complete healing did not differ significantly.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Prospective randomized comparative trial35A public evidence table lists Faculty of Medicine Siriraj Hospital; the paper's complete funding statement was not verifiedTime to complete wound closure of partial-thickness burns10.0±3.0 versus 13.7±4.3 days, P<0.02; independently calculated mean difference -3.7 days (95% CI -5.44 to -1.96)Pivotal closure-time trial
Study 2Open-label parallel-group randomized comparative trial27Original text: ‘Source of Support: DST West Bengal’At least 50% healing and complete healing by four weeksAt least 50% healing in deep partial-thickness burns: 25/31 versus 13/27, independently calculated RR 1.67 (95% CI 1.09-2.56); complete healing 4% versus 0%, P=0.116Supportive trial using a different product and outcome
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-14).

Muangman P, Pundee C, Opasanon S, Muangman S. A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns. Int Wound J. 2010;7(4):271-276. PMID: 20528992. DOI: 10.1111/j.1742-481X.2010.00690.x.
checked
Adhya A, Bain J, Ray O, et al. Healing of burn wounds by topical treatment: A randomized controlled comparison between silver sulfadiazine and nano-crystalline silver. J Basic Clin Pharm. 2014;6(1):29-34. PMID: 25538469. DOI: 10.4103/0976-0105.145776.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-14 · Corrections: none

Cite this verdict

Modern silver-containing dressings x partial-thickness burn closure Evidence Grade C card
[Chamgap] Modern silver-containing dressings x partial-thickness burn closure — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/modern-silver-dressings-vs-silver-sulfadiazine-partial-thickness-burn-closure/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.